Literature DB >> 29762205

Bleach for Atopic Dermatitis.

Melody Maarouf1, Vivian Y Shi2.   

Abstract

Individuals with atopic dermatitis (AD) have used bleach baths to treat superinfections, although their mechanism of action is not well understood. The ClinicalTrials.gov, National Eczema Association, and PubMed databases were searched for studies that investigate the role bleach plays in modulating AD. Fifteen studies were included in this review. Bleach bath improves clinical symptoms of AD and restores surface microbiome by eradicating bacteria, most notably Staphylococcus aureus. Many studies have noted that this antimicrobial effect has reduced the need for topical corticosteroids or topical antibiotics. In addition, bleach seems to have strong anti-inflammatory and antipruritogenic effects. Lastly, bleach baths seem to be safe on human skin, without disrupting epidermal barrier function. Although the effects of bleach are promising, studies that investigate the long-term use of bleach alone, without concomitant AD treatment modalities, are needed. The emergence of new bleach-containing products warrants future investigations to examine their effects on cutaneous microbiome, epidermal barrier function, and immunity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29762205     DOI: 10.1097/DER.0000000000000358

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  9 in total

1.  Pathophysiology of atopic dermatitis: Clinical implications.

Authors:  Jihyun Kim; Byung Eui Kim; Donald Y M Leung
Journal:  Allergy Asthma Proc       Date:  2019-03-01       Impact factor: 2.587

Review 2.  Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis.

Authors:  Rhea Singh; Courtney E Heron; Rima I Ghamrawi; Lindsay C Strowd; Steven R Feldman
Journal:  Immunotargets Ther       Date:  2020-11-10

Review 3.  Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP).

Authors:  Elena Galli; Anna Belloni Fortina; Giampaolo Ricci; Nunzia Maiello; Iria Neri; Ermanno Baldo; Irene Berti; Domenico Bonamonte; Lucetta Capra; Elena Carboni; Rossella Carello; Francesca Caroppo; Giovanni Cavagni; Iolanda Chinellato; Francesca Cipriani; Pasquale Comberiati; Andrea Diociaiuti; Vito Di Lernia; Marzia Duse; Cesare Filippeschi; Arianna Giannetti; Mattia Giovannini; Amelia Licari; Gian Luigi Marseglia; Manuela Pace; Annalisa Patrizi; Giovanni Battista Pajno; Diego Peroni; Alberto Villani; Lawrence Eichenfield
Journal:  Ital J Pediatr       Date:  2022-06-14       Impact factor: 3.288

Review 4.  Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies.

Authors:  Chia-Yu Chu
Journal:  Clin Rev Allergy Immunol       Date:  2021-10       Impact factor: 8.667

5.  Emollient formulations containing antiseptics reduce effectively the level of Staphylococcus aureus on skin.

Authors:  Fabrizio Spada; Tanya M Barnes; Kerryn A Greive
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-09-04

Review 6.  The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities.

Authors:  Laura J Klesse; Justin T Jordan; Heather B Radtke; Tena Rosser; Elizabeth Schorry; Nicole Ullrich; David Viskochil; Pamela Knight; Scott R Plotkin; Kaleb Yohay
Journal:  Oncologist       Date:  2020-04-22

7.  Microbiologic characterisation of bacterial infections in children with atopic dermatitis.

Authors:  Nkosinathi O Zwane; Josiah T Masuka; Antoinette V Chateau; Anisa Mosam
Journal:  S Afr J Infect Dis       Date:  2022-03-31

Review 8.  Interactions Between Atopic Dermatitis and Staphylococcus aureus Infection: Clinical Implications.

Authors:  Jihyun Kim; Byung Eui Kim; Kangmo Ahn; Donald Y M Leung
Journal:  Allergy Asthma Immunol Res       Date:  2019-09       Impact factor: 5.764

9.  What's new in atopic eczema? An analysis of systematic reviews published in 2018. Part 1: prevention and topical therapies.

Authors:  F Tasker; A Brown; D J C Grindlay; N K Rogers; K E Harman
Journal:  Clin Exp Dermatol       Date:  2020-08-27       Impact factor: 3.470

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.